Onconic Therapeutics Statistics

Total Valuation

KOSDAQ:476060 has a market cap or net worth of KRW 272.72 billion. The enterprise value is 227.75 billion.

Market Cap	272.72B
Enterprise Value	227.75B

Important Dates

The last earnings date was Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:476060 has 11.06 million shares outstanding.

Current Share Class	11.06M
Shares Outstanding	11.06M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.75%
Owned by Institutions (%)	13.47%
Float	5.28M

Valuation Ratios

The trailing PE ratio is 59.66.

PE Ratio	59.66
Forward PE	n/a
PS Ratio	9.27
PB Ratio	4.62
P/TBV Ratio	4.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 104.43, with an EV/FCF ratio of -53.72.

EV / Earnings	49.82
EV / Sales	7.74
EV / EBITDA	104.43
EV / EBIT	133.40
EV / FCF	-53.72

Financial Position

The company has a current ratio of 12.10, with a Debt / Equity ratio of 0.00.

Current Ratio	12.10
Quick Ratio	11.65
Debt / Equity	0.00
Debt / EBITDA	0.10
Debt / FCF	-0.05
Interest Coverage	108.89

Financial Efficiency

Return on equity (ROE) is 9.95% and return on invested capital (ROIC) is 2.31%.

Return on Equity (ROE)	9.95%
Return on Assets (ROA)	2.15%
Return on Invested Capital (ROIC)	2.31%
Return on Capital Employed (ROCE)	2.89%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.59
Inventory Turnover	n/a

Taxes

Income Tax	-2.25B
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	24,473.00
200-Day Moving Average	n/a
Relative Strength Index (RSI)	47.96
Average Volume (20 Days)	170,279

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:476060 had revenue of KRW 29.43 billion and earned 4.57 billion in profits.

Revenue	29.43B
Gross Profit	29.42B
Operating Income	1.71B
Pretax Income	2.32B
Net Income	4.57B
EBITDA	2.18B
EBIT	1.71B
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 45.19 billion in cash and 218.33 million in debt, giving a net cash position of 44.97 billion or 4,064.52 per share.

Cash & Cash Equivalents	45.19B
Total Debt	218.33M
Net Cash	44.97B
Net Cash Per Share	4,064.52
Equity (Book Value)	58.98B
Book Value Per Share	n/a
Working Capital	50.51B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.98 billion and capital expenditures -258.02 million, giving a free cash flow of -4.24 billion.

Operating Cash Flow	-3.98B
Capital Expenditures	-258.02M
Free Cash Flow	-4.24B
FCF Per Share	-383.19

Full Cash Flow Statement

Margins

Gross margin is 99.99%, with operating and profit margins of 5.80% and 15.54%.

Gross Margin	99.99%
Operating Margin	5.80%
Pretax Margin	7.88%
Profit Margin	15.54%
EBITDA Margin	7.41%
EBIT Margin	5.80%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:476060 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.68%
FCF Yield	-1.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:476060 has an Altman Z-Score of 29 and a Piotroski F-Score of 2.

Altman Z-Score	29
Piotroski F-Score	2